Pharma Journalist - Page 35 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

GSK Acquires Exclusive Rights to Syndivia’s Next-Generation ADC for Advanced Prostate Cancer

Eli Lilly to Acquire Adverum Biotechnologies in $1.5 Billion Deal to Advance Gene Therapy for Vision Loss

Alkermes to Acquire Avadel in $2.1 Billion Deal to Expand Into Sleep Medicine Market

Ipsen to Acquire ImCheck Therapeutics to Boost Immuno-Oncology Pipeline

FDA Approves GSK’s Blenrep Combo for Relapsed or Refractory Multiple Myeloma

Takeda and Innovent Partner in $1.2 Billion Deal to Advance Late-Stage Cancer Drugs Globally

Ventus Therapeutics Teams Up with Genentech for AI-Driven Drug Discovery Collaboration

Roche’s Tecentriq Shows Survival Benefit in ctDNA-Guided Bladder Cancer Trial

EMA Backs Approval of GSK’s Shingrix in New Prefilled Syringe Format

Just announced: AI in Drug Discovery 2026 agenda